Veterans urge TN lawmakers to fund trials of psychoactive drug

Tennessee lawmakers are weighing whether to fund clinical trials of ibogaine, a psychedelic compound advocates say could help veterans and others with PTSD and addiction.

The Helping Open Pathways to Effective (HOPE) Treatment Act was introduced in January and remains under consideration in both Senate and House committees. Advocates rallied for action on the proposal at the state Capitol Feb. 24.

Ibogaine, pronounced i-bow-gain, is illegal for use ...

Continue Reading →
The year in review: A Mugglehead roundup

The year 2025 in review: A Mugglehead roundup

Blink and 2025 is going to be over. Pop the cork. Hallelujah.

The year was defined by a weird mix of volatility, breakthroughs, and sharp reminders of how fast technology, markets, and medicine can shift. Precious metals surged on global uncertainty as wars and violence made investors head for safe haven assets. Medical diagnostics and psychedelic therapies incorporated artificial intelligence and inched towards the mainstream.

Investor behavior told a similar story. In periods of ...

Continue Reading →
UA-77446339-1